Search Results
Brianna
"He was the king of positivity" is what Dr. McCarthy at Roswell Park said to me the day after my Dad passed away from complications of GVHD or graft-versus-host disease. My Dad was a leader, someone who was always willing to help others, and always had a smile on his face. Not only was I his co-caregiver throughout his cancer journey, but he was also my caregiver during mine.
Rick
Rick Ostroff and his family have a legacy of philanthropy with a heartfelt connection to a disease he never had. During the first three years of his life, he spent time on the leukemia floor of Children’s Hospital in Boston but eventually was found to have the critical illness of gamma globulin anemia rather than then-fatal leukemia.
Tawilhua
My name is Tee, and I am a survivor of multiple myeloma (MM), a rare blood cancer. Before my diagnosis, I was an active principal at the school where I worked, was involved in my community, and lived a life of purpose. And then I was diagnosed with the “Big C.”
Today, I still have a purpose-filled life, it simply looks different than before. Telling my cancer story is a part of living a fulfilled life after a cancer diagnosis. So here is Tee’s story.
Glenis
The body is ultimately wise. Through this most recent medical ordeal, I learned to listen to what my body was telling me. In 2018, I felt symptoms above and beyond the fibromyalgia ailments that I had been plagued with for 25 years. I had unusual inflammation despite eating healthy and walking on a regular basis. I developed an unrelenting throb of pain in my lower back. My internal medicine doctor at the time dismissed my complaints.
Pharmacological strategies to enhance T- and NK-cell-based therapies in blood cancers
Although they represent a major therapeutic progress for blood cancers, CAR-T cells and other T-cell based therapies are subject to eventual development of resistance to many patients. Natural killer (NK) cell-based therapies are highly active against many types of blood cancer cells which are resistant to T cells, but in our CRISPR studies death receptor signaling defects emerge as a common downstream mechanism of resistance to both T- and NK-cell therapies.
Donna
The year 2021 was quite a year for us. It was the year of cancer. No one ever really prepares themselves for the diagnosis of cancer, and when you're told you have it, the emotional roller coaster you are about to embark on cannot ever be fully described in words. The fear, the exhaustion, the financial burden, the feeling of helplessness you experience is completely terrifying. In the year 2021, we started the fight of all fights, the fight to save my husband's life. This is our story of cancer. Our story of love, life, hope, and healing.